Work

LuCarbo: A phase 1a/1b trial of 177 Lu-PSMA-617 (LuPSMA) with carboplatin in advanced prostate cancer.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.tps304

Authors: Praful Ravi, Wanling Xie, Morgan Paul, Erin Healy, Amanda Lilienfeld, Nicole LaBrecque, Andrew Wolanski, Jolivette Ritzer, Michael Thomas Serzan, Alok Tewari, Heather Jacene

Institutions: Dana-Farber Cancer Institute, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Dana-Farber/Harvard Cancer Center

OpenAlex ID: W4407678529

FWCI:

Cites:

Cited by:

Related to: 10